14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MNKD
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for MannKind Corporation
(Updated on Apr 24, 2024)

Sell candidate since Apr 10, 2024 Loss -1.18% PDF

The MannKind Corporation stock price gained 0.721% on the last trading day (Wednesday, 24th Apr 2024), rising from $4.16 to $4.19. During the last trading day the stock fluctuated 3.37% from a day low at $4.15 to a day high of $4.29. The price has been going up and down for this period, and there has been a -1.18% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 768 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $7.38 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.15 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 24.35% during the next 3 months and, with a 90% probability hold a price between $5.16 and $7.29 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MNKD Signals & Forecast

There are mixed signals in the stock today. The MannKind Corporation stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.49. On a fall, the stock will find some support from the short-term average at $4.12. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -20.49%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for MannKind Corporation stock

MannKind Corporation finds support from accumulated volume at $4.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.140 between high and low, or 3.37%. For the last week, the stock has had daily average volatility of 3.85%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MNKD) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect MannKind Corporation to open at $4.21, and during the day (based on 14 day Average True Range), to move between $3.99 and $4.39, which gives a possible trading interval of +/-$0.197 (+/-4.71%) up or down from last closing price. If MannKind Corporation takes out the full calculated possible swing range there will be an estimated 9.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.11 (1.91%) than the resistance at $4.50 (7.40%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MannKind Corporation stock A Buy?

MannKind Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.047 Sell Candidate Unchanged

Predicted Opening Price for MannKind Corporation of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$4.21 ( 0.477%) $4.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MNKD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.35 3.82 %
R2 4.30 2.54 %
R1 4.26 1.75 %
Current price: 4.19
Support S1 4.16 -0.799 %
S2 4.12 -1.59 %
S3 4.07 -2.86 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.15 22.91 %
R2 4.61 10.02 %
R1 4.50 7.40 %
Current price 4.19
Support S1 4.11 -1.91%
S2 3.92 -6.44%
S3 3.60 -14.08%

FAQ

What is the symbol for MannKind Corporation Stock and on which exchange is it traded?
The symbol for MannKind Corporation is MNKD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MannKind Corporation Stock?
MannKind Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy MannKind Corporation Stock?
MannKind Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MannKind Corporation Stock.

What's the current price of MannKind Corporation Stock?
As of the end of day on the Apr 24, 2024, the price of an MannKind Corporation (MNKD) share was $4.19.

What is the 52-week high and low for MannKind Corporation Stock?
The 52-week high for MannKind Corporation Stock is $5.75 and the 52-week low is $3.17.

What is the market capitalization of MannKind Corporation Stock?
As of the Apr 24, 2024, the market capitalization of MannKind Corporation is 1.133B.

When is the next earnings date for MannKind Corporation?
The upcoming earnings date for MannKind Corporation is May 14, 2024.
Click to get the best stock tips daily for free!

About MannKind Corporation

MannKind MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a licens... MNKD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT